Clinical laboratory test Market is estimated to grow at the CAGR of 6.5% by 2022

Market Highlights

It has been noted that global clinical laboratory test market is growing at steady pace and is expected to grow at the CAGR of 6.5%. Clinical laboratory testing has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment.

The rate of various disease and disorder like diabetes, cancer and much infectious disease has risen in last few years. According to the survey by WHO, by 2030 diabetes will be the seventh leading cause of death, in 2012 approximately 1.5 million people died due to diabetes. On other hand 14 million patients in 2012 to 22 million on a yearly basis new cancer cases are been registered. The Centres for Disease Control and Prevention reported that in 2012 alone, US reported 9,945 cases of tuberculosis, 53,800 cases of salmonella, 30,831 new cases of Lyme disease and 551 cases of meningococcal disease. The light footed increment in the chronic disease condition has impact on the demand for clinical laboratory services.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1649

Major Key Players:

• AURORA Diagnostics
• Laboratory Corporation of America
• LifeLabs Medical Laboratories
• Quest Diagnostics
• Sonic Healthcare and others

Regional analysis

North America accounts for the maximum market share of Global Clinical Laboratory testing market and is expected to grow at a CAGR of 6.2% during the forecasted period. Maximum number of laboratories and clinical testing procedures are the major reason for the highest market growth of this region. Asia-Pacific, is expected to be the fastest growing region with the CAGR of 6.8% during the forecasted period mainly because of growing awareness about various medical test, government support in order to improve healthcare sector, innovation of new tests and procedures by major market players. The awareness and patient counselling with respect to medical testing by Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicines which includes the members from seven nations. Being a large population base, multiplying aging population and continuous advance in healthcare, China clinical laboratory market has been growing radically in recent years.

Taste the market data and market information presented in more than 59 market data tables and 30 figures spread over 88 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “Global Clinical laboratory test Market Research Report -Forecast till 2022.”

Access Report Details @ https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

Segmentation
Global clinical laboratory test market has been segmented on the basis of laboratory type which comprises of hospital based laboratories, central/independent laboratories, physician office laboratory (pol) and others. Furthermore on the bases of laboratory tests the market is segmented into cbc and other routine blood tests, anatomic pathology, molecular tests, immunology tests, drug testing and others.

Globally Clinical Laboratory Testing Market by type of laboratory test is segmented into CBC and routine blood test, anatomical pathology, molecular pathology, immunological testing, drug testing and other routine tests. In 2016, CBC and other routine test accounts for the largest market share of 50.9%, and was valued at USD 105230.6 Million in the same year. This large share is majorly attributed to factor such as increasing outpatient services in hospitals and increasing awareness and concern regarding routine health check-ups. Drug testing laboratory tests are projected to grow at a higher CAGR of 6.9% during the forecasted period due to increase in demand for new drugs for treatment of disease and also due to increased testing relating to prescription drug abuse. Various laboratories in North America provide clinical testing services, Quest diagnostics, and LabCorp are the major providers of these services in North America region and contributes largest market share together. Regulating government policies are the major restricting factor in the clinical laboratory testing market.

Table of Contents

1 Report Prologue
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
Continued…..

Browse Related Statistical Reports

Asia intraoperative neurophysiological monitoring market is expected to grow at a rate of 9.3% during the forecasted period. The major market is accounted by Japan registering $70.9 million revenue and it is expected to reach by $200.1 million by 2027.

https://www.marketresearchfuture.com/statistical-reports/asia-intraoperative-neurophysiological-monitoring-market-3049

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.